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Toll-like receptors are key elements in pathogen recognition by the host immune system. Although the expression
pattern and functions of Toll-like receptors have been studied in a variety of cytokine-induced dendritic cells, it
remains unknown whether Toll-like receptor stimulation inﬂuences maturation and cytokine production of
authentic Langerhans cells. We puriﬁed murine epidermal Langerhans cells along with splenic dendritic cell using
a panning method. Langerhans cells expressed Toll-like receptor 2, 4, and 9 but not 7, the pattern of which
suggests Langerhans cells are the closest to one of the murine dendritic cell lineage, CD11cþ11bþ8a–4–. Then we
stimulated Toll-like receptor 2, 4, and 9 with the corresponding ligand, Staphylococcus aureus Cowan 1,
lipopolysaccharide, and CpG, and found that all of these stimuli upregulated expression of B7-1 and B7-2 in splenic
dendritic cells but not in Langerhans cells. As in human Langerhans cells, stimulation of murine Langerhans cells
with Staphylococcus aureus Cowan 1, lipopolysaccharide, and CpG overall resulted in T helper 1-polarizing
cytokine production (namely, induction of IL-12p40 and inhibition of TARC (thymus and activation-regulated
chemokine)/CCL17). Exceptionally, lipopolysaccharide exhibited no effect on IL-12p40 production by Langerhans
cells and inhibited IL-12p40 production by splenic dendritic cells. These results may represent the functional
heterogeneity between Langerhans cells and splenic dendritic cells, and are important for better understanding of
innate immunity to bacterial infections differentially regulated in the skin and spleen. MeSH terms: Toll-like
receptors, Langerhans cells, dendritic cells.
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Toll-like receptors (TLR) represent a family of type I
transmembrane proteins that are characterized by an
extracellular leucine-rich repeat domain and a cytoplasmic
domain similar to interleukin (IL)-1 receptor (Belvin and
Anderson, 1996). TLR mediate an innate immune response
by directly recognizing pathogen-associated molecular
patterns that are common among a large group of
pathogens (Aderem and Ulevitch, 2000; Akira et al, 2001).
For example, TLR2 mediates cellular responses to Staphy-
lococcus aureus Cowan 1 (SAC) and peptidoglycan (Heine
et al, 1999; Schwandner et al, 1999; Takeuchi et al, 1999;
Underhill et al, 1999; Yoshimura et al, 1999). Similarly, TLR3
is required for the response to viral double-stranded RNA
(Alexopoulou et al, 2001), TLR4 is for the lipopolysaccharide
(LPS) (Poltorak et al, 1998; Chow et al, 1999; Hoshino et al,
1999; Takeuchi et al, 1999), TLR7 is for the imiquimod
(Hemmi et al, 2002), and TLR9 is for the unmethylated CpG
motif abundant in bacterial DNA (Hemmi et al, 2000). As for
TLR4, two additional molecules, CD14 and MD2, are known
to be essential in maintaining the functional integrity of this
receptor (Shimazu et al, 1999; Akashi et al, 2000; Yang et al,
2000; da Silva and Ulevitch, 2002). RP105 is another
transmembrane protein that, like TLR4, transduces LPS
signaling. RP105 has an extracellular leucine-rich repeat but
lacks an IL-1 receptor domain, and is physically associated
with MD1, an MD2-like molecule (Miyake et al, 1998, 2000).
Interestingly, most of these microbial ligands for TLR have
similar effects on dendritic cells (DC); they recruit an
adaptor protein MyD88 to the receptor complex and
activate intracellular signaling largely through nuclear
factor-kB (Medzhitov et al, 1998). In the case of TLR4
stimulation with LPS, the presence of MyD88-independent
signaling pathway that mediates nuclear factor-kB activa-
tion is suggested (Akira et al, 2001). Signaling through TLR
strongly activates DC to upregulate costimulatory mole-
cules (B7-1 and B7-2) and to induce proinflammatory
cytokines, including tumor necrosis factor-a, IL-6, and IL-
12 (Brightbill et al, 1999; Takeuchi et al, 2000a,b; Thoma-
Uszynski et al, 2000; Edwards et al, 2002). The investigation
into TLR functions of DC has been of great interest as
it remains unclear how cytokine production by DC is
regulated and attributed to pathogen recognition.
Epidermal Langerhans cells are bone marrow-derived,
major histocompatibility complex class II antigen-bearing
antigen-presenting cells that comprise 1 to 3% of total
Abbreviations: ODN, oligodeoxynucleotides; SAC, Staphy-
lococcus aureus Cowan 1; TARC, thymus and activation-
regulated chemokine; TLR, Toll-like receptors.
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epidermal cells (Katz et al, 1979). Murine DC subsets have
been classified into six populations (Kelsall et al, 2002):
(1) three (CD11cþ11bþ8a–4–, CD11cþ11bþ8a–4þ , and
CD11cþ11b–8aþ ) exist in the spleen, peripheral lymph
nodes, and Peyer’s patches; (2) mesenteric lymph nodes
contain two additional populations (CD11cþ11blo8a–4– and
CD11cþ langerinþ ); and (3) a plasmacytoid DC precursor
(CD11cintGr-IþB220þ ) exists in lymphoid tissues and
blood. In particular, CD11cþ langerinþ DC subtypes are
found only in skin-draining lymph nodes and believed to be
the mature form of Langerhans cells (Henri et al, 2001).
These six subsets show qualitative and quantitative
differences in the expression of TLR (Kelsall et al, 2002);
CD11cþ11bþ8a–4– DC express TLR2, TLR4, and TLR9,
CD11cþ11bþ8a–4þ DC express TLR7 and TLR9,
CD11cþ11b–8aþ DC express TLR3 and TLR9, and a
plasmacytoid DC precursor expresses TLR7 and TLR9;
however, little is known about TLR recognition by Langer-
hans cells because of the paucity of Langerhans cells in the
epidermis. In this study we applied a classical panning
technique that has been proven as a powerful tool when
examining the functions of resident (namely authentic)
Langerhans cells (Salgado et al, 1999) and compared the
expression pattern and functions of TLR between epidermal
Langerhans cells and splenic DC. We mainly focused on
TLR2, TLR4, TLR7, and TLR9 in terms of, and for the better
understanding of, innate immunity to bacterial infections of
the skin.
Results
Fresh Langerhans cells express TLR2, TLR4, TLR9, and
RP105 mRNA but not TLR7 mRNA mRNA samples were
extracted from Langerhans cells (fresh), splenic DC, and
keratinocytes and analyzed with reverse transcription–
polymerase chain reaction to detect specific TLR tran-
scripts. To minimize contamination, only splenic DC
samples with a purity of  95% (as well as Langerhans
cells) were used in this experiment. As shown in Fig 1(a),
TLR2 and TLR4 transcripts were present in Langerhans
cells, splenic DC, and keratinocytes. In contrast, TLR9 and
RP105 mRNA were expressed by Langerhans cells and
splenic DC, but not by keratinocytes. TLR7 mRNA was
absent in all three types of cells other than splenic DC. The
lack of TLR7 expression on Langerhans cells was further
confirmed by the preliminary experiment showing that IL-6,
IL-12p40, and TARC production by Langerhans cells stayed
unchanged regardless of stimulation with imiquimod (data
not shown). Interestingly, CD14 mRNA was present in
splenic DC but not in Langerhans cells or keratinocytes.
MD2 and MyD88 mRNA expression was demonstrated in all
three types of cells (data not shown). MD1 mRNA was
detected in Langerhans cells and splenic DC but not in
keratinocytes (data not shown).
Next, we examined the protein expression of TLR2,
TLR4, and RP105 in Langerhans cells (fresh) and splenic
DC. The expression of TLR2 was confirmed by immuno-
blotting (Fig 1b); however, we could not show cell surface
expression of TLR2 as the MoAb used for immunoblotting
did not work with flow cytometry. The cell surface
expression of TLR4 and RP105 was detected on Langer-
hans cells as determined by flow cytometry analysis (Fig
1c). The mean fluorescence intensity (MFI) of TLR4 and
RP105 in splenic DC was  8 and  16 times higher than
that in Langerhans cells, respectively. Splenic DC but not
Langerhans cells was immunoreactive for CD14.
Stimulation of TLR (SAC, LPS, and CpG) drives matura-
tion of splenic DC but not of Langerhans cells As it was
reported that maturation of murine splenic DC is driven by
TLR stimulation (Edwards et al, 2002), we cultured
Langerhans cells and splenic DC (positive control) for 18
or 36 h with or without 1:10,000 diluted SAC, 1 mg LPS per
mL, 6 mg CpG ODN 1668 per mL, or 10 ng GM-CSF per mL
(positive control) and compared the MFI of I-Ad, B7-1, and
B7-2. GM-CSF upregulated B7-1 and B7-2 (but not I-Ad)
expression on Langerhans cells and splenic DC during 18 or
36 h of culture (Fig 2). Addition of SAC, LPS, or CpG ODN
1668 to splenic DC resulted in upregulation of B7-1 and B7-
2 (but not of I-Ad), which was consistent with a previous
study (Edward et al, 2002). The MFI of these major
histocompatibility complex class II and costimulatory
molecules on Langerhans cells, however, remained un-
changed regardless of deliberate stimulation of TLR (Fig 2).
Figure1
Murine Langerhans cells express TLR2, TLR4, TLR9, and PR105
but not TLR7. (a) mRNA samples from Langerhans cells, splenic DC,
and keratinocytes were reverse transcribed. The resultant cDNA was
amplified using the primers described in Materials and Methods. The
size of products is as follows: TLR2, 922 bp; TLR4, 556 bp; TLR7, 656
bp; TLR9, 542 bp; CD14, 1327 bp; RP105, 787 bp; G3PDH, 640 bp. NC
denotes negative control. (b) Protein samples from Langerhans cells,
splenic DC, and 2D6 were immunolabeled with anti-TLR2 antibody. The
apparent size of TLR2 is 92 kDa. (c) Langerhans cells and splenic DC
were analyzed for expression of TLR4, RP105, and CD14 (bold lines)
by flow cytometry. Thin lines indicate isotype control staining. The
results shown in the figure are representative of three independent
experiments.
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LPS upregulates cell surface expression of TLR4 in
splenic DC but not in Langerhans cells As it has been
shown that TLR4 expression is upregulated in human and
murine DC with LPS treatment (Gatti et al, 2000; Muzio et al,
2000; Visintin et al, 2001; An et al, 2002), we examined if it is
also the case with murine resident Langerhans cells. We
cultured Langerhans cells and splenic DC (positive control)
for 36 h in the presence or absence of LPS and measured
the MFI of TLR4. The cell surface expression of TLR4
showed relatively modest upregulation in splenic DC by LPS
(Fig 3), which confirms the findings of others (Gatti et al,
2000; Muzio et al, 2000; Visintin et al, 2001; An et al, 2002).
On the contrary, no remarkable change in the TLR4
expression was observed in Langerhans cells regardless
of whether LPS were added to the cultures (Fig 3).
SAC induces IL-6 and IL-12p40 production by Langer-
hans cells and splenic DC, inhibits TARC production
by Langerhans cells, and shows no effect on TARC
production by splenic DC The production of IL-6 (inflam-
matory cytokine), IL-12p40 (T helper (Th)1-polarizing cyto-
kine), and TARC (Th2 cytokine) by Langerhans cells and
splenic DC was determined by ELISA. Although the purity of
splenic DC fluctuated over 80%, we continued to use the
positive selection technique because we wanted to isolate
Langerhans cells and splenic DC with as similar conditions
as possible, namely, using a single MoAb to avoid
unnecessary stimulation. Fortunately, cytokine production
by DC showed drastic changes with each stimulation to
TLR, and there was no significant difference between
results obtained by three independent experiments in which
splenic DC with respective purities of 82%, 88%, and 94%
were used. Thus, we combined the results of three
experiments in each graph (Fig 4a–i ).
Langerhans cells and splenic DC were cultured with or
without 1:10,000 diluted SAC, and culture supernatant was
harvested after 36 h. SAC induced IL-6 and IL-12p40
production by Langerhans cells (Fig 4a,b). A similar
induction by SAC was also observed in splenic DC (Fig
4a,b). On the other hand, SAC inhibited TARC/CCL17
production by Langerhans cells (Fig 4c), whereas splenic
DC showed no significant change in TARC production in the
absence or presence of SAC (Fig 4c).
LPS induces IL-6 production by Langerhans cells and
splenic DC, inhibits IL-12p40 production by splenic DC
and TARC production by Langerhans cells, and shows
no effect on IL-12p40 production by Langerhans cells
and TARC production by splenic DC Similar to SAC-
stimulated Langerhans cells and splenic DC, LPS induced
IL-6 production by Langerhans cells and by splenic DC (Fig
4d ). Of note, IL-12p40 production by Langerhans cells was
unchanged with or without LPS stimulation (Fig 4e).
Furthermore, LPS inhibited IL-12p40 production by splenic
DC (Fig 4e). As with the case of treatment with SAC and
CpG, LPS also inhibited TARC production by Langerhans
cells and showed no effect on splenic DC (Fig 4f ).
CpG induces IL-6 and IL-12p40 production by Langer-
hans cells and splenic DC, inhibits TARC production
by Langerhans cells, and shows no effect on TARC
Figure 2
Stimulation of TLR (SAC, LPS, and CpG) drives maturation of
splenic DC but not of Langerhans cells. Langerhans cells and splenic
DC were cultured for 18 h (a) or 36 h (b) with or without SAC (1:10,000
diluted), LPS (1 mg per mL), CpG ODN1668 (6 mg per mL), or GM-CSF
(10 ng per mL), and assessed for expression of I-Ad, B7-1, or B7-2 by
flow cytometry. Cells cultured with TLR stimulation (bold lines) were
compared with cells cultured without TLR stimulation (dotted lines).
Stimulation of splenic DC with SAC, LPS, CpG, or GM-CSF (positive
control) resulted in upregulation of B7-1, and B7-2 (but not of I-Ad). No
upregulation of I-Ad, B7-1, and B7-2 was observed on Langerhans
cells. Data shown are representative of three separate experiments.
Figure3
LPS upregulates cell surface expression of TLR4 in splenic DC but
not in Langerhans cells. Langerhans cells and splenic DC were
cultured for 36 h in the presence or absence of LPS (1 mg per mL). The
cell surface expression of TLR4 was significantly upregulated by LPS in
splenic DC, but not in Langerhans cells. Similar results were obtained in
three independent experiments.
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production by splenic DC Basically, regulation of cytokine
production by Langerhans cells and splenic DC in response
to CpG ODN was the same as that in response to SAC. The
IL-6 and IL-12p40 production by Langerhans cells were
enhanced in the presence of 6 mg CpG ODN 1668 per mL
(Fig 4g,h). This enhancement was less obvious when using
CpG ODN 1668m, and production of these two cytokines
returned to around the baseline with CpG ODN 1720 (Fig
4g,h). Using splenic DC, the change in IL-6 and IL-12p40
production exhibited the same tendency (Fig 4g,h). A series
of CpG treatment experiments indicated that the unmethy-
lated, specific CpG motif is crucial for the induction of IL-6
and IL-12p40 by Langerhans cells. TARC production by
Langerhans cells was impaired by bacterial CpG motif
(Fig 4i ). TARC production by splenic DC stayed unchanged
with the stimulation of CpG ODN1668, 1668m, and 1720
compared with that without stimulation (Fig 4i ). All these
data suggest that signaling to TLR is differentially pro-
cessed between Langerhans cells and splenic DC in terms
of IL12p40 and TARC production.
Discussion
DC are professional antigen-presenting cells that have an
ability to mediate specific acquired immunity by stimulating
naive T cells or by maintaining peripheral T cell tolerance
(Liu, 2001; Mellman and Steinman, 2001). It was recently
shown that human and murine DC express functional TLR
and play an important part in innate immunity. For example,
TLR2 and TLR4 interaction with the corresponding ligand is
essential for bacterial-induced maturation and cytokine
secretion of murine DC (Michelsen et al, 2001). TLR9 is
another molecule that is expressed on murine DC and
involved in bacterial infection (An et al, 2002). In this study,
we focused on the role of TLR2, TLR4, and TLR9 using
epidermal Langerhans cells and splenic DC, both are
resident cells isolated and purified with the classical
panning method, in order to compare their functional
differences mediated through TLR. Almost all of DC studies
have been performed with cytokine DC induced from
CD34þ precursor cells or mononuclear cells by GM-CSF
and IL-4 (Sallusto and Lanzavecchia, 1994). It has not
fully been proven, however, that such cytokine-induced DC
are absolutely equal to the resident DC and that
CD11cþ langerinþ DC can be regarded as identical to
epidermal Langerhans cells. In fact, most monocyte-
derived DC are different from Langerhans cells in many
respects, including lack of Birbeck granules, expression of
chemokine receptors, and expression of mannose recep-
tors (Banchereau and Steinman, 1998; Grassi et al, 1998;
Sozzani et al, 1999). We constantly achieved more than
95% purity of murine Langerhans cells and used them in the
series of experiments.
DC are heterogeneous in terms of ontogeny, phenotype,
and function (Banchereau and Steinman, 1998). As deli-
neated in the introduction, murine DC subsets are classified
into six populations so far (Kelsall et al, 2002). Interestingly,
these six subsets show qualitative and quantitative differ-
ences in the expression of TLR (Kelsall et al, 2002):
CD11cþ11bþ8a–4– DC express TLR2, TLR4, and TLR9,
CD11cþ11bþ8a–4þ DC express TLR7 and TLR9,
CD11cþ11b–8aþ DC express TLR3 and TLR9, and a
plasmacytoid DC precursor expresses TLR7 and TLR9.
The expression pattern of TLR on some populations,
including Langerhans cells (CD11cþ langerinþ ), has yet to
be determined, however. Resident Langerhans cells
showed mRNA expression of TLR2, TLR4, and TLR9 but
not TLR7, and protein expression was further confirmed as
to TLR2 and TLR4. This expression pattern of Langerhans
cells was the same as that of CD11cþ11bþ8a–4– DC,
suggesting that Langerhans cells are the closest to this
splenic DC population from the perspective of the TLR
expression. With regard to human DC, it has been shown
that myeloid DC express TLR2 and TLR4, whereas
plasmacytoid DC express TLR7 and TLR9 (Jarrossay et al,
2001; Kadowaki et al, 2001; Krug et al, 2001). Our data
Figure 4
SAC, LPS, and CpG induce IL-6 and IL-12p40 production by murine
resident Langerhans cells and inhibit TARC/CCL17 production,
with the only exception is that LPS shows no effect on IL-12p40
production. Langerhans cells and splenic DC were cultured with or
without SAC (1:10,000 diluted), LPS (1 mg per mL), or CpG ODN 1668 (6
mg per mL). Cytokine levels in the supernatants were measured after 36
h. SAC induced IL-6 and IL-12p40 production by Langerhans cells or
by splenic DC (a,b). SAC, however, inhibited TARC production by
Langerhans cells, whereas splenic DC did not show any significant
change in TARC production in the absence or presence of SAC (c). LPS
induced IL-6 production by Langerhans cells or by splenic DC (d). Of
note, IL-12p40 production by Langerhans cells stayed unchanged with
or without LPS stimulation (e). Furthermore, LPS inhibited IL-12p40
production by splenic DC (e). LPS inhibited TARC production by
Langerhans cells and showed no effect on splenic DC (f). The IL-6 and
IL-12p40 production by Langerhans cells or by splenic DC were
enhanced in the presence of CpG ODN 1668, but not of CpG ODN
1668m (6 mg per mL) or ODN 1720 (6 mg per mL) (g, h). CpG impaired
TARC production by Langerhans cells (i). TARC production by splenic
DC stayed unchanged with the stimulation of CpG (i). All values are
expressed as mean  SD (n¼3 in each group). Significance of
differences was determined by paired two-tailed Student’s t-test
(po0.05). NS stands for not significant. In g–i (þ ) denotes stimulation
with CpG ODN 1668 (m) with 1668m, and (n) with 1720, respectively.
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reveal that TLR expression pattern of murine DC is different
from that of human DC.
Several lines of evidence indicate that freshly purified
murine epidermal Langerhans cells resemble ‘‘immature
Langerhans cells’’ and cultured Langerhans cells can be
regarded as ‘‘mature Langerhans cells’’ in terms of cell
structure and function. While migrating to the lymph nodes,
Langerhans cells start to express and augment I-Ad antigen,
costimulatory/accessory molecules, including B7-1, B7-2,
and CD40 for efficient T cell activation (Schuler and
Steinman, 1985; Winzler et al, 1997; Gallucci et al, 1999).
This ‘‘maturation’’ process is considered to be supported by
keratinocyte-derived cytokines, such as GM-CSF, IL-1, and
tumor necrosis factor-a (Witmer-Pack et al, 1987; Heufler
et al, 1988; Koch et al, 1990; Ozawa et al, 1996). Previous
data demonstrated that cell surface expression of I-Ad,
B7-1, B7-2, and CD40 on murine Langerhans cells cultured
for 2 to 3 d with those cytokines was upregulated when
compared with that of Langerhans cells cultured without
cytokines (Chang et al, 1994, 1995; Salgado et al, 1999).
Recently, it was shown that maturation of murine splenic DC
is driven by TLR stimulation (Edwards et al, 2002), and we
could also confirm that SAC, LPS, and CpG ODN1668
upregulate B7-1 and B7-2 (but not of I-Ad) expression on
splenic DC. Surprisingly, and interestingly, all three stimuli to
TLR did not upregulate cell surface expression of B7-1 and
B7-2 on murine Langerhans cells. We concluded that the
part of maturation process (as to upregulation of B7-1 and
B7-2) modulated and mediated through TLR is differentially
regulated between Langerhans cells and splenic DC, which
might represent functional diversity of antigen presentation
in various organs. Similarly, our additional experiment
demonstrated that murine epidermal Langerhans cells was
unresponsive to LPS in terms of cell surface expression of
TLR4, which was sharply contradictory to the finding that
TLR4 expression is upregulated in human and murine DC
with LPS treatment (Gatti et al, 2000; Muzio et al, 2000;
Visintin et al, 2001; An et al, 2002).
DC govern the development of T cell-mediated immune
response into either Th1 or Th2 response, depending on the
types of stimulation and pathogens (d’Ostiani et al, 2000;
Whelan et al, 2000). As IL-12 has been implicated as
an important factor from DC that direct Th1 response
(Banchereau and Steinman, 1998), we focused on the
production of IL-12 (Th1-polarizing cytokine) and TARC (Th2
cytokine) as well as IL-6 (proinflammatory cytokine) induced
by stimulation to TLR2, TLR4, and TLR9. TLR stimulation
activates human DC and induces production of IL-6 and IL-
12 (Thoma-Uszynski et al, 2000; Kadowaki et al, 2001; Krug
et al, 2001). In the murine system, LPS and CpG stimulation
have been reported to augment tumor necrosis factor-a
production by cytokine-induced DC (An et al, 2002). In this
study, TLR2, TLR4, and TLR9 interaction with the corre-
sponding ligand (SAC, LPS, and CpG) induced IL-6 and IL-
12p40 production by murine Langerhans cells and inhibited
TARC production; the only exception was that LPS showed
no effect on IL-12p40 production, as demonstrated by
others using splenic DC (Pulendran et al, 2001; Boonstra
et al, 2003). Regarding Th1/Th2 balance, almost all three
stimuli resulted in a Th1-mediated immune response both in
Langerhans cells and splenic DC, as shown in human DC by
others. In order to determine whether cytokine production
is directly mediated through TLR4, we added anti-TLR4
antibody that was used for immunoblotting to culture
media, but the antibody did not cancel the effect of LPS
on cytokine production (data not shown), probably because
the antibody possessed no blocking effect. Alternatively,
signaling induced by LPS might have been mediated
through RP105. To deny the latter possibility, we compared
Langerhans cells and splenic DC from C3H/HeN and C3H/
HeJ mice, which are closely related strains but different in
their ability to respond to LPS. A functional TLR4 is present
in C3H/HeN but absent in C3H/HeJ mice (Eden et al, 1988;
Poltorak et al, 1998; Qureshi et al, 1999). LPS induced IL-6
production by Langerhans cells and splenic DC from C3H/
HeN mice but not by Langerhans cells and splenic DC from
C3H/HeJ mice, suggesting LPS activates TLR4 signaling
both in Langerhans cells and splenic DC (data not shown).
The experiments in this study demonstrated that LPS
enhanced IL-6 production much more by splenic DC than
by Langerhans cells, which might be elucidated by the fact
that MFI of TLR4, RP105, and CD14 was higher in splenic
DC than in Langerhans cells. Also, SAC and CpG induced
IL-6 production much more by splenic DC than by
Langerhans cells. We speculate that the significant differ-
ences in responsiveness to LPS and CpG might represent
biologic significance, along with the fact that stimulation
with SAC, LPS, and CpG induced maturation of splenic DC
(but not of Langerhans cells), which might be a deliberately
built-in system in order to prevent Langerhans cells from
unnecessary excessive response to ubiquitous bacteria
from the external environment, most of them lack patho-
genesis. Our preliminary in vivo functional experiments,
however, showed that there was no difference in the
intensity of contact hypersensitivity between C3H/HeN
and C3H/HeJ mice when LPS in a single dose of 100 mg
was injected intraperitoneally 36 or 18 h before and after
sensitization (data not shown). When elucidating the whole
output of innate immune reactions to LPS in the skin, all of
the components, their functions, and complicated interac-
tions between them should be taken into account. It is
highly possible that keratinocytes, a major component of
the epidermis, might play a supplementary role in the
cutaneous immune system and cancel out the differences in
responsiveness to LPS between Langerhans cells from
C3H/HeN and Langerhans cells from C3H/HeJ mice, as
mRNA expression for TLR2 and TLR4 was demonstrated in
this study, and others have reported that human keratino-
cytes express functional TLR4 (Song et al, 2002).
Collectively, we demonstrated TLR2, TLR4, and TLR9
expression both in Langerhans cells and splenic DC and
their functional heterogeneity. TLR play an essential part in
the recognition of bacterial components, and the differ-
ences in responsiveness to microorganisms between
Langerhans cells and splenic DC might be for exerting a
different immune response appropriate for each organ. We
anticipate that analysis of the functional diversity of TLR will
contribute to further understanding of ‘‘organ-specific’’
immunity, manipulating immune responses associated
with bacterial infection of the skin, and therefore allow
development of novel therapeutic modalities for various
infectious and inflammatory skin diseases.
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Materials and Methods
Animals BALB/C female mice were purchased from Japan SLC
Co. (Hamamatsu, Japan), and maintained under specific patho-
gen-free conditions at the University of Tokyo Animal Facilities until
use at the age of 8 to 12 wk.
Antibodies and reagents The following monoclonal antibodies
(MoAb) and immunoglobulin isotypes were used for immunostain-
ing. Fluorescein isothiocyanate-conjugated mouse anti-mouse I-Ad,
mouse anti-mouse CD11cþ , mouse IgG2b, k (isotype control),
hamster anti-mouse B7-1, rat anti-mouse CD14, rat IgG1,2
(isotype control), rat anti-mouse B7-2, and rat IgG2b, k (isotype
control) were obtained from Pharmingen (San Diego, California).
Phycoerythrin-conjugated rat anti-mouse TLR4, rat anti-mouse
RP105, and rat IgG2a,k (isotype control) were obtained from
eBioscience (San Diego, California). Recombinant murine granu-
locyte-macrophage colony stimulating factor (GM-CSF) (Pepro-
tech, Rocky Hill, New Jersey) was diluted and stored according to
the manufacturer’s guidelines. SAC (pansorbin) was purchased
from Calbiochem (San Diego, California), and LPS (serotype 0111:
B4) was from Sigma-Aldrich (St Louis, Missouri). CpG oligodeox-
ynucleotides (ODN) 1668 (containing the CpG motif), 1668m
(methylated derivative), and 1720 (with an inverted CpG motif)
were synthesized by QIAGEN (Tokyo, Japan) as follows: 1668 50-
TCC ATG ACG TTC CTG ATG CT-30, 1668m 50-TCC ATG AXG TTC
CTG ATG CT-30 (X, 5-methyl-deoxycytidine) 1720 50-TCC ATG AGC
TTC CTG ATG CT-30 (Deng et al, 1999).
Puriﬁcation and culture of Langerhans cells and splenic
dendritic cells Langerhans cells were isolated and purified using
a previously described panning method (Salgado et al, 1999).
Briefly, murine skin was treated with dispase (3000 U per mL, Godo
Shusei Co., Tokyo, Japan) in RPMI1640 supplemented with 10%
fetal calf serum (RPMI10) for 3 h at 371C. Epidermis was separated
from dermis and incubated in RPMI10 containing 0.025% DNase I
(Sigma-Aldrich) for 20 min at room temperature. Epidermal cell
suspension was obtained by vigorous pipetting of the resultant
epidermal sheets, and then reacted with 1:600 diluted mouse anti-
mouse I-Ad MoAb (Cedarlane Co., Ontario, Canada) in RPMI10 for
45 min on ice. The cells were incubated in plates coated with 1:100
diluted goat anti-mouse IgG (Fc) (Organon Teknika, Durham, North
Carolina) for 45 min at 41C. After washing out floating cells,
adherent cells were collected and designated as purified Langer-
hans cells. The purity of Langerhans cells was consistently over
95% as determined by flow cytometry using fluorescein isothio-
cyanate-conjugated mouse anti-mouse I-Ad MoAb (data not
shown). The freshly isolated Langerhans cells demonstrated
Birbeck granules in their cytoplasm by electron microscopy, and
showed marked cell surface expression of CD40, B7-1, and B7-2
molecules upon stimulation (data not shown and Salgado et al,
1999), which indicated that the cells are not completely activated.
The floating cells were collected before washing and designated as
keratinocytes.
DC were purified from murine spleen. Single cell suspension
was obtained by gentle teasing with forceps and rubbers, and
filtered through a nylon mesh. Erythrocytes were lyzed by NH4Cl
treatment. From the remaining unfractionated cell populations,
CD11cþ cells were separated by positive magnetic selection using
microbead-conjugated hamster anti-mouse CD11c MoAb (Mitenyl
Biotec, Belgisch Gladbach, Germany) and a magnetic cell separator
according to the manufacturer’s instructions. The purity of CD11cþ
cells was consistently over 80% as determined by flow cytometry
using fluorescein isothiocyanate-conjugated mouse anti-mouse
CD11c MoAb (data not shown) and designated as splenic DC.
In the culture experiment, purified Langerhans cells and splenic
DC were in 96-well flat-bottom plates at density of 1.0  106 cells
per mL for 18 or 36 h. Cultures were incubated with or without
different stimuli, including SAC, LPS, and CpG ODN in RPMI10
containing 100 U per mL penicillin G sodium, 100 mg streptomycin
sulfate per mL, and 0.25 mg amphotericin B per mL. The viability of
cultured Langerhans cells and splenic DC was carefully checked in
each experiment. None of the TLR stimulations used influenced
cell viability (data not shown).
Reverse transcription–polymerase chain reaction Purified Lan-
gerhans cells, splenic DC, and keratinocytes were lyzed and mRNA
was extracted using the Quickprep Micro mRNA Purification Kit
(Pharmacia Biotech, Uppsala, Sweden). About 100 ng of mRNA
was obtained from 1.0  106 cells. cDNA was synthesized using
First-Strand cDNA Synthesis Kit (Pharmacia Biotech) and then
amplified by 35 cycles of polymerase chain reaction (941C for 45 s,
601C for 1 min, and 721C for 1 min) with primers for G3PDH sense
50-CAG GAG CGA GAC CCC ACT AA-30 and anti-sense 50-GGC
ATC GAA GGT GGA AGA GT-30. The primers used for amplification
of TLR2 (Underhill et al, 1999), TLR4 (Akashi et al, 2000), MD2
(Akashi et al, 2000), TLR7 (Bruno et al, 2001), TLR9 (Bruno et al,
2001), MyD88 (Harroch et al, 1995), RP105 (Miyake et al, 1995),
CD14 (Matsuura et al, 1992), and MD-1 (Miyake et al, 1998) were
described elsewhere. Products were fractionated by 1% agarose
gel electrophoresis, stained with ethidium bromide and viewed on
an ultraviolet transilluminator.
Flow cytometry analysis Cells were washed and stained in
phosphate-buffered saline containing 0.1% bovine serum albumin
and 0.1% NaN3 (fluorescence-activated cell sorter buffer). Cells
were incubated with 1:50 diluted fluorescein isothiocyanate-
conjugated anti-TLR4, anti-RP105, anti-CD14, anti-I-Ad, anti-B7-
1, or anti-B7-2 MoAb for 30 min at 41C. Propidium iodide was
added to exclude dead cells. Cell acquisition was performed on
FACSCalibur flow cytometer (Becton Dickinson, San Diego,
California), and data were analyzed using CELLQuest software
(Becton Dickinson).
Immunoblotting For detecting TLR2 expression, cells were lyzed
with buffer containing 50 mM Tris–Cl (pH 7.4), 150 mM NaCl, 1%
Nonidet P-40, 0.25% sodium deoxycholate, 5 mM EDTA, and ele-
ctrophoresed in 7.5% sodium dodecyl sulfate–polyacrylamide gels.
The proteins in the gels were electrotransferred on to PVDF mem-
branes (Millipore, Bedford, Massachusetts) and probed with 1:200
diluted goat anti-mouse TLR2 polyclonal IgG antibody (Santa Cruz,
California). 2D6 T cell clone was used as negative control of TLR2
(a kind gift from Dr Fujiwara, Biomedical Research Center, Osaka
University Medical School, Osaka, Japan) (Maruo et al, 1997).
Measurement of IL-6, IL-12p40, and TARC/CCL17 by ELISA Cul-
ture supernatants of Langerhans cells and splenic DC were
subjected to the quantification of IL-6, IL-12p40, and thymus
and activation-regulated chemokine (TARC)/CCL17 by ELISA using
commercially available mouse IL-6, IL-12p40, and TARC immuno-
assay kits (R&D Systems, Minneapolis, Minnesota) according to the
manufacturer’s instructions. Each sample was tested in duplicate.
Statistical analysis The paired two-tailed Student’s t-test was
used to analyze the results and a p-value less than 0.05 was
considered significant.
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